Thomas Coates

Author PubWeight™ 87.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood 2005 6.07
2 Successes and challenges of HIV prevention in men who have sex with men. Lancet 2012 4.94
3 Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infect Dis 2011 4.72
4 AIDS. Promote HIV chemoprophylaxis research, don't prevent it. Science 2005 4.44
5 Factors associated with self-efficacy for condom use and sexual negotiation among South african youth. J Acquir Immune Defic Syndr 2006 2.21
6 Social networking technologies as an emerging tool for HIV prevention: a cluster randomized trial. Ann Intern Med 2013 1.97
7 Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood 2009 1.83
8 HIV-related stigma, social norms, and HIV testing in Soweto and Vulindlela, South Africa: National Institutes of Mental Health Project Accept (HPTN 043). J Acquir Immune Defic Syndr 2010 1.78
9 A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol 2007 1.77
10 The relationship between online social networking and sexual risk behaviors among men who have sex with men (MSM). PLoS One 2013 1.74
11 Linkage to HIV care and survival following inpatient HIV counseling and testing. AIDS Behav 2011 1.66
12 Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection. AIDS 2007 1.60
13 Implementation and evaluation of an HIV/STD intervention in Peru. Eval Program Plann 2006 1.55
14 Vulnerability and sexual risks: Vagos and vaguitas in a low income town in Perú. Cult Health Sex 2006 1.53
15 Test and tell: correlates and consequences of testing and disclosure of HIV status in South Africa (HPTN 043 Project Accept). J Acquir Immune Defic Syndr 2009 1.53
16 Missed opportunities for HIV testing and late-stage diagnosis among HIV-infected patients in Uganda. PLoS One 2011 1.50
17 Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay. J Acquir Immune Defic Syndr 2009 1.46
18 Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection. PLoS One 2011 1.46
19 Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease. Br J Haematol 2011 1.45
20 Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME). Transfusion 2013 1.43
21 Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). PLoS One 2013 1.40
22 Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial. PLoS One 2013 1.24
23 Potential for false positive HIV test results with the serial rapid HIV testing algorithm. BMC Res Notes 2012 1.24
24 Moderno love: sexual role-based identities and HIV/STI prevention among men who have sex with men in Lima, Peru. AIDS Behav 2013 1.24
25 Looking to the future: South African men and women negotiating HIV risk and relationship intimacy. Cult Health Sex 2011 1.22
26 Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. Haematologica 2008 1.18
27 Sexual risk and HIV prevention behaviours among African-American and Latino MSM social networking users. Int J STD AIDS 2013 1.17
28 Mobile VCT: reaching men and young people in urban and rural South African pilot studies (NIMH Project Accept, HPTN 043). AIDS Behav 2013 1.17
29 Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study. Clin Infect Dis 2006 1.13
30 The HOPE social media intervention for global HIV prevention in Peru: a cluster randomised controlled trial. Lancet HIV 2015 1.13
31 Effect of a community popular opinion leader HIV/STI intervention on stigma in urban, coastal Peru. AIDS Behav 2011 1.11
32 Project HOPE: online social network changes in an HIV prevention randomized controlled trial for African American and Latino men who have sex with men. Am J Public Health 2014 1.11
33 Pain as an emergent issue in thalassemia. Am J Hematol 2010 1.10
34 Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia. Clin Ther 2007 1.06
35 Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major. Br J Haematol 2008 1.05
36 [Influence of socio-cultural context on risk perception and negotiation of protection among poor homosexual males on the Peruvian coast]. Cad Saude Publica 2006 1.04
37 Use of non-occupational post-exposure prophylaxis does not lead to an increase in high risk sex behaviors in men who have sex with men participating in the EXPLORE trial. AIDS Behav 2010 0.99
38 Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort. Blood 2012 0.98
39 HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043). BMC Infect Dis 2011 0.97
40 USING PARTICIPATORY METHODS AND GEOGRAPHIC INFORMATION SYSTEMS (GIS) TO PREPARE FOR AN HIV COMMUNITY-BASED TRIAL IN VULINDLELA, SOUTH AFRICA (Project Accept-HPTN 043). J Community Psychol 2009 0.97
41 Iron chelation adherence to deferoxamine and deferasirox in thalassemia. Am J Hematol 2011 0.93
42 Treating thalassemia major-related iron overload: the role of deferiprone. J Blood Med 2012 0.92
43 Electrocardiographic consequences of cardiac iron overload in thalassemia major. Am J Hematol 2011 0.91
44 Pain in thalassaemia: the effects of age on pain frequency and severity. Br J Haematol 2012 0.91
45 Prevention of the sexual transmission of HIV-1: preparing for success. J Int AIDS Soc 2008 0.90
46 Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. Hemoglobin 2004 0.89
47 Low-shear red blood cell oxygen transport effectiveness is adversely affected by transfusion and further worsened by deoxygenation in sickle cell disease patients on chronic transfusion therapy. Transfusion 2012 0.89
48 Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): an initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC). Pediatr Blood Cancer 2013 0.88
49 Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial. Acta Haematol 2008 0.88
50 Antibody maturation and viral diversification in HIV-infected women. PLoS One 2013 0.88
51 Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin 2006 0.84
52 Response to Ronald Gray, Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda ( 2000, 14:2371-2381). AIDS 2002 0.81
53 Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors. AIDS Res Hum Retroviruses 2009 0.80
54 Quantitative computed tomography assessment of transfusional iron overload. Br J Haematol 2011 0.79
55 Pulmonary hypertension does not affect the autonomic nervous system dysfunction of sickle cell disease. Am J Hematol 2009 0.79
56 Predicting pituitary iron and endocrine dysfunction. Ann N Y Acad Sci 2010 0.79
57 Iron chelation in thalassemia: time to reconsider our comfort zones. Expert Rev Hematol 2011 0.78
58 Atrial dysfunction as a marker of iron cardiotoxicity in thalassemia major. Haematologica 2008 0.78
59 Exercise performance in thalassemia major: correlation with cardiac iron burden. Am J Hematol 2013 0.77
60 Combining two orally active iron chelators for thalassemia. Ann Hematol 2010 0.77
61 Cobalamin C disease presenting with hemophagocytic lymphohistiocytosis. Pediatr Hematol Oncol 2005 0.76
62 Moving the bar to the right place: positioning interventions in HIV prevention. AIDS Behav 2014 0.75
63 Variance of pain prevalence and associated severity during the transfusion cycle of adult thalassaemia patients. Br J Haematol 2014 0.75
64 Increased leucocyte apoptosis in transfused β-thalassaemia patients. Br J Haematol 2012 0.75
65 Learning to Live With HIV in the Rural Townships: A Photovoice Study of Men Who Have Sex With Men Living With HIV in Mpumalanga, South Africa. J Assoc Nurses AIDS Care 2017 0.75
66 Depression, gay men, and HIV acquisition. Focus 2004 0.75